Sen, M.K.; Almuslehi, M.S.M.; Shortland, P.J.; Mahns, D.A.; Coorssen, J.R.
Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers. Int. J. Mol. Sci. 2021, 22, 7377.
https://doi.org/10.3390/ijms22147377
AMA Style
Sen MK, Almuslehi MSM, Shortland PJ, Mahns DA, Coorssen JR.
Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers. International Journal of Molecular Sciences. 2021; 22(14):7377.
https://doi.org/10.3390/ijms22147377
Chicago/Turabian Style
Sen, Monokesh K., Mohammed S. M. Almuslehi, Peter J. Shortland, David A. Mahns, and Jens R. Coorssen.
2021. "Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers" International Journal of Molecular Sciences 22, no. 14: 7377.
https://doi.org/10.3390/ijms22147377
APA Style
Sen, M. K., Almuslehi, M. S. M., Shortland, P. J., Mahns, D. A., & Coorssen, J. R.
(2021). Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers. International Journal of Molecular Sciences, 22(14), 7377.
https://doi.org/10.3390/ijms22147377